This report studies the global Neurostimulation Devices market status and forecast, categorizes the global Neurostimulation Devices market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.
Request Sample Copy of the Report @ https://www.qyresearch.com/sample-form/form/263646/global-neurostimulation-devices-sales-market
The global average price of implantable neurostimulation devices is in the fluctuating trend, 22.10 K USD/Unit in 2012 to 21.24 K USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of implantable neurostimulation devices includes spinal cord stimulation (SCS), gastric electric stimulation (GES), deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagus nerve stimulation (VNS) and other type, and the proportion of spinal cord stimulation (SCS) in 2016 is about 57%, and the proportion is in increasing trend from 2012 to 2016.
Implantable neurostimulation devices are widely used to treat pain management, parkinson’s disease, urinary and fecal incontinence, epilepsy, gastroparesis and other field. The most proportion of implantable neurostimulation devices is used for pain management, and the consumption proportion in 2016 is about 55%.
North America region is the largest supplier of implantable neurostimulation devices, with a production market share nearly 82% in 2016. Europe is the second largest supplier of implantable neurostimulation devices, enjoying production market share nearly 12% in 2016.
You can also Request for a Discount- https://www.qyresearch.com/request-discount/form/263646/global-neurostimulation-devices-sales-market
North America is the largest consumption place, with a consumption market share nearly 42% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Medtronic, Boston Scientific, St. Jude Medical (Abbott), etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Neurostimulation Devices market is valued at 4290 million US$ in 2017 and will reach 10100 million US$ by the end of 2025, growing at a CAGR of 11.3% during 2018-2025.
The major players covered in this report
- Boston Scientific
- St. Jude Medical (Abbott)
- Beijing Pins
Click to view the full report TOC, figure and tables: https://www.qyresearch.com/index/detail/263646/global-neurostimulation-devices-sales-market
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.
QY Research, INC.
City of industry, CA – 91748
USA: +1 626 295 2442
Email – firstname.lastname@example.org
Web – www.qyresearch.com
For other region, contact number given below
- +86 108 294 5717 Beijing
- +86 208 665 5165 Guangzhou
- +86 215 160 1757 Shanghai
- +852 3062 8839 HK
- +1 613 366 5094 Canada
- +81 903 800 9273 Japan
- +49 176 813 78371Germany
- +44 203 734 8135 UK
- +33 172 813 308 France
- +55 613 181 0478 Brazil
- +91 114 046 9822 India